AAAAAA

   
Results: 1-14 |
Results: 14
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
Authors: Contos, MJ Cales, W Sterling, RK Luketic, VA Shiffman, ML Mills, AS Fisher, RA Ham, J Sanyal, AJ
Citation: Mj. Contos et al., Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis, LIVER TRANS, 7(4), 2001, pp. 363-373
Bleeding esophageal varices - How to treat this dreaded complication of portal hypertension
Authors: Hegab, AM Luketic, VA
Citation: Am. Hegab et Va. Luketic, Bleeding esophageal varices - How to treat this dreaded complication of portal hypertension, POSTGR MED, 109(2), 2001, pp. 75
A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response
Authors: Shiffman, ML Hofmann, CM Sterling, RK Luketic, VA Contos, MJ Sanyal, AJ
Citation: Ml. Shiffman et al., A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response, J INFEC DIS, 184(4), 2001, pp. 405-409
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
Authors: Sanyal, AJ Campbell-Sargent, C Mirshahi, F Rizzo, WB Contos, MJ Sterling, RK Luketic, VA Shiffman, ML Clore, JN
Citation: Aj. Sanyal et al., Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities, GASTROENTY, 120(5), 2001, pp. 1183-1192
Esophageal varices I. Clinical presentation, medical therapy, and endoscopic therapy
Authors: Luketic, VA Sanyal, AJ
Citation: Va. Luketic et Aj. Sanyal, Esophageal varices I. Clinical presentation, medical therapy, and endoscopic therapy, GASTRO CLIN, 29(2), 2000, pp. 337
Esophageal varices II. TIPS (transjugular intrahepatic portosystemic shunt) and surgical therapy
Authors: Luketic, VA Sanyal, AJ
Citation: Va. Luketic et Aj. Sanyal, Esophageal varices II. TIPS (transjugular intrahepatic portosystemic shunt) and surgical therapy, GASTRO CLIN, 29(2), 2000, pp. 387
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: Comparison of hepatic histology and response to interferon therapy
Authors: Shiffman, ML Stewart, CA Hofmann, CM Contos, MJ Luketic, VA Sterling, RK Sanyal, AJ
Citation: Ml. Shiffman et al., Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: Comparison of hepatic histology and response to interferon therapy, J INFEC DIS, 182(6), 2000, pp. 1595-1601
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: Effects of higher doses of interferon and ribavirin combination therapy
Authors: Shiffman, ML Hofmann, CM Gabbay, J Luketic, VA Sterling, RK Sanyal, AJ Contos, MJ Ryan, MJ Yoshida, C Rustgi, V
Citation: Ml. Shiffman et al., Treatment of chronic hepatitis C in patients who failed interferon monotherapy: Effects of higher doses of interferon and ribavirin combination therapy, AM J GASTRO, 95(10), 2000, pp. 2928-2935
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis
Authors: Combes, B Markin, RS Wheeler, DE Rubin, R West, AB Mills, AS Eigenbrodt, EH Maddrey, WC Munoz, SJ Garcia-Tsao, G Bonner, GF Boyer, JL Luketic, VA Shiffman, ML Peters, MG White, HM Zetterman, RK Carithers, RL
Citation: B. Combes et al., The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis, HEPATOLOGY, 30(3), 1999, pp. 602-605
Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholicacid
Authors: Combes, B Carithers, RL Maddrey, WC Munoz, S Garcia-Tsao, G Bonner, GF Boyer, JL Luketic, VA Shiffman, ML Peters, MG White, H Zetterman, RK Risser, R Rossi, SS Hofmann, AF
Citation: B. Combes et al., Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholicacid, HEPATOLOGY, 29(6), 1999, pp. 1649-1654
A randomized, controlled trial of maintenance inteferon therapy for patients with chronic hepatitis C virus and persistent viremia
Authors: Shiffman, ML Hofmann, CM Contos, MJ Luketic, VA Sanyal, AJ Sterling, RK Ferreira-Gonzalez, A Mills, AS Garret, C
Citation: Ml. Shiffman et al., A randomized, controlled trial of maintenance inteferon therapy for patients with chronic hepatitis C virus and persistent viremia, GASTROENTY, 117(5), 1999, pp. 1164-1172
Chronic hepatitis C infection in patients with end stage renal disease: Characterization of liver histology and viral load in patients awaiting renaltransplantation
Authors: Sterling, RK Sanyal, A Luketic, VA Stravitz, RT King, AL Post, AB Mills, AS Contos, MJ Shiffman, ML
Citation: Rk. Sterling et al., Chronic hepatitis C infection in patients with end stage renal disease: Characterization of liver histology and viral load in patients awaiting renaltransplantation, AM J GASTRO, 94(12), 1999, pp. 3576-3582
Treatment of fulminant hepatic failure with intravenous prostaglandin E-1
Authors: Sterling, RK Luketic, VA Sanyal, AJ Shiffman, ML
Citation: Rk. Sterling et al., Treatment of fulminant hepatic failure with intravenous prostaglandin E-1, LIVER TR S, 4(5), 1998, pp. 424-431
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation
Authors: Fisher, RA Ham, JM Marcos, A Shiffman, ML Luketic, VA Kimball, PM Sanyal, AJ Wolfe, L Chodorov, A Posner, MP
Citation: Ra. Fisher et al., A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation, TRANSPLANT, 66(12), 1998, pp. 1616-1621
Risultati: 1-14 |